Jan 14, 2016
‘Fountain Of Youth:’ New Hormone Prolongs Lifespan, Decreases Negative Effects Of Aging In Mice
Posted by Sean Brazell in categories: biotech/medical, life extension
I was shocked to learn recently that one of the major reasons longevity drugs haven’t been going to human trials, despite obvious promise, is that the FDA requires that any potential drug trial has to have a disease or condition it treats. Because aging hasn’t been seen as a disease or medical condition, no drug trials have been allowed to go forward to treat it. NONE! Finally, late last year, aging has been OFFICIALLY recognized as a disease and is therefor now a valid target disease for drug trials. **sigh**.
Are we one step closer to developing compounds that can extend our lifespan?